NEW ORLEANS — At the Ophthalmology Innovation Summit, Mark Baum, CEO of Imprimis Pharmaceuticals, discusses two new formulations for use in cataract surgery.
Uncategorized
Uncategorized
VIDEO: Novaliq announces full enrollment in phase 2 trial of dry eye treatment
NEW ORLEANS — At the Ophthalmology Innovation Summit, Bernhard Günther, CEO of Novaliq, gives an update on the company portfolio, including news that it had completed enrollment in a phase 2 study of CyclASol for the treatment of moderate to severe dry eye disease.
Portable artificial vision device may be an effective aid for patients with low vision
In a small study that included 12 legally blind participants, use of a portable artificial vision device improved the patient’s ability to perform tasks simulating those of daily living, such as…
RetroSense Therapeutics to Highlight Contributions to Gene Therapy Research in Upcoming Conferences
ANN ARBOR, Mich.–(BUSINESS WIRE)–CEO Sean Ainsworth will highlight RetroSense’s contributions to gene therapy research during panel presentations at the NY BIO 2016 Annual Meeting and the Piper Jaffray GenomeRx Symposium.
Uncategorized
ARMOR study shows antibiotic resistance levels remain high
SEATTLE – Preliminary 2015 data from the Antibiotic Resistance Monitoring in Ocular Microorganism study show that high levels of antibiotic resistance continue among Staphylococcus, especially the methicillin-resistant strains, according to a poster presented here at the Association of Research in Vision and Ophthalmology meeting. Christine Sanfilippo, PhD, manager of pharmaceutical medical affairs, Bausch + Lomb, told Primary Care Optometry News, “There’s relatively no change in overall trends from 2014. No change means everyone is using good antibiotic stewardship practices.”
Global Glaucoma Market 2016 – Valuations, Analysis & Forecast – Research and Markets
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Global Glaucoma Market and Competitive Landscape Highlights – 2016” report to their offering. The latest research report provides comprehensive insights into pipeline prod…